Company: SHPH
Filing Date: 2025-02-28
Form Type: 8-K
Source: 0001493152-25-008742
Chunk: 2

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-28
Form: 8-K
Item: Item 1.01
Chunk 2
---
 all officers
and directors during the term of any Revolving Loan, (iii) repurchases of common stock or common stock equivalents, pursuant to existing
repurchase agreements, provided that such repurchases shall not exceed an aggregate of $25,000 during the term of any Revolving Loan,
or (iv) shares of common stock and common stock equivalents which do not vest or are otherwise forfeited, provided (in case of forfeiture)
that such common stock and common stock equivalents are not acquired for cash;

The
foregoing descriptions of the Revolving Note Agreement and the Revolving Note are qualified in their entirety by reference to the full
text of such agreements, copies of which are attached hereto as Exhibits 10.1 and 10.2, respectively, and each of which is incorporated
herein in its entirety by reference.

Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant